Transfusion as a predictor of recurrence and survival in head and neck cancer surgery patients

Journal of Otolaryngology - Head and Neck Surgery

Volumn 39, Issue 5, 2010, Pages 516-522

  Chau, Jason K M ^a,b   Harris, Jeffery R ^a   Seikaly, Hadi R ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b STANFORD UNIVERSITY   (United States)

Author keywords

Cancer recurrence; Head and neck cancer; Leukodepleted blood

Indexed keywords

ADULT; ALLOGENEIC PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; ARTICLE; BLOOD BANK; BLOOD TRANSFUSION; CANCER MORTALITY; CANCER RECURRENCE; CANCER REGISTRY; CANCER SURGERY; CANCER SURVIVAL; ERYTHROCYTE TRANSFUSION; FEMALE; HEAD AND NECK CANCER; HUMAN; HYPOPHARYNX CANCER; LARYNX CANCER; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OROPHARYNX CANCER; OUTCOME ASSESSMENT; PERIOPERATIVE PERIOD; PREDICTION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; SALIVARY GLAND CANCER; STATISTICAL SIGNIFICANCE; THYROID CANCER;

ALBERTA; BLOOD TRANSFUSION, AUTOLOGOUS; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PERIOPERATIVE CARE; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 77957204896     PISSN: 19160216     EISSN: None     Source Type: Journal    
DOI: 10.2310/7070.2010.090256     Document Type: Article

References (41)

1. Martin H. Surgery of head and neck tumors. New York: Hoeber-Harper Books; 1957.
2. Chau JKM, Dzigielewski P, Mlynarek A, et al. Steel scalpel versus electrocautery blade: comparison of cosmetic and patient satisfaction outcomes of different incision methods. J Otolaryngol Head Neck Surg 2009;38:427-33.
3. Dulguerov P, Quinodiz D, Abdelkaram SA, et al. Blood transfusion requirements in otolaryngology-head and neck surgery. Acta Otolaryngol (Stockh) 1998;118:744-7. (Pubitemid 28505613)
4. Sataloff RT, Brown ACD, Sheets EE, et al. A controlled study of hypotensive anesthesia in head and neck surgery. Ear Nose Throat J 1987;66:479-85.
5. Ell SR, Stell PM. Blood transfusion and survival after laryngectomy for laryngeal carcinoma. J Laryngol Otol 1991;105:293-4.
6. Davis M, Sofer M, Gomoez-Martin O, et al. The use of cell salvage during radical prostatectomy: does it influence cancer recurrence? BJM Int 2003;91:474-6.
7. Opelz G, Sengar DP, Mickey MR, Teraski PI. Effect of blood transfusions on subsequent kidney transplants. Transplant Proc 1973;5:253-9.
8. Blajchman MA. Immunomodulation and blood transfusion. Am J Ther 2002;9:389-95.
9. Chiarugi M, Buccianti P, Disarli M, et al. Effect of blood transfusions on disease-free interval after rectal cancer surgery. Hepatogastroenterology 2000;47:1002-5.
10. Amato AC, Pescatori M. Effect of perioperative blood transfusions on recurrence of colorectal cancer: meta-analysis stratified on risk factors. Dis Colon Rectum 1998;41:570-85. (Pubitemid 28224088)
11. Edna TH, Bjerkeset T. Perioperative blood transfusions reduce long-term survival following surgery for colorectal cancer. Dis Colon Rectum 1998;41:451-9. (Pubitemid 28169670)
12. Busch OR, Hop WC, Marquet RL, Jeekel J. Blood transfusions and local tumor recurrence in colorectal cancer. Evidence of a noncausal relationship. Ann Surg 1994;220:791-7.
13. Heiss MM, Mempel W, Delanoff C, et al. Blood transfusion-modulated tumor recurrence: first results of a randomized study of autologous versus allogeneic blood transfusion in colorectal cancer surgery. J Clin Oncol 1994;12:1859-67.
14. Hyung WJ, Noh SH, Shin DW, et al. Adverse effects of perioperative transfusion on patients with stage III and IV gastric cancer. Ann Surg Oncol 2002;9:5-12. (Pubitemid 34262891)
15. Dresner SM, Lamb PJ, Shenfine J, et al. Prognostic significance of peri-operative blood transfusion following radical resection for oesophageal carcinoma. Eur J Surg Oncol 2000;26:492-7.
16. Tachibana M, Tabara H, Kotoh T, et al. Prognostic significance of perioperative blood transfusions in respectable thoracic esophageal cancer. Am J Gastroenterol 1999;94:757-65. (Pubitemid 29124878)
17. Pysz M. Blood transfusions in breast cancer patients undergoing mastectomy: possible importance of timing. J Surg Oncol 2000;75:258-63.
18. Makino Y, Yamanoi A, Kimoto T, et al. The influence of perioperative blood transfusion on intrahepatic recurrence after curative resection of hepatocellular carcinoma. Am J Gastroenterol 2000;95:1294-300. (Pubitemid 30263527)
19. Asahara T, Katayama K, Itamota T, et al. Perioperative blood transfusion as a prognostic indicator in patients with hepatocellular carcinoma. World J Surg 1999;23:676-80. (Pubitemid 29314408)
20. Santin AM, Bellone S, Parrish RS, et al. Influence of allogeneic blood transfusion on clinical outcome during radiotherapy for cancer of the uterine cervix. Gynecol Obstet Invest 2003;56:28-34. (Pubitemid 37025944)
21. Spirtos NM, Westby CM, Averette HE, Soper JT. Blood transfusion and the risk of recurrence in squamous cell carcinoma of the cervix: a Gynaecologic Oncology Group study. Am J Clin Oncol 2002;25:398-403. (Pubitemid 34864037)
22. Leon X, Quer M, Luz Maestre M, et al. Blood transfusions in laryngeal cancer: effect on prognosis. Head Neck 1996;18:218-24.
23. Bock M, Gravers G, Koblitz M, et al. Influence of blood transfusion on recurrence, survival and postoperative infections of laryngeal cancer. Acta Otolaryngol (Stockh) 1990;110:155-60. (Pubitemid 20206998)
24. Von Doersten P, Cruz RM, Selby JV, Hilsinger RL Jr. Transfusion, recurrence and infection in head and neck cancer surgery. Otolaryngol Head Neck Surg 1992;106:60-7.
25. Schuller DE, Scott C, Wilson KM, et al. The effect of perioperative blood transfusion on survival in head and neck cancer. Arch Otolaryngol Head Neck Surg 1994;120:711-6. (Pubitemid 24217583)
26. Moir MS, Samy RN, Hanasono MM, Terris DJ. Autologous and heterologous blood transfusion in head and neck cancer surgery. Arch Otolaryngol Head Neck Surg 1999;125:864-8.
27. Jones KR, Weissler MC. Blood transfusion and other risk factors for recurrence of cancer of the head and neck. Arch Otolaryngol Head Neck Surg 1990;116:304-9.
28. Alun-Jones T, Clarke PJ, Morrissy S, Hill J. Blood transfusion and laryngeal cancer. Clin Otolaryngol 1991;16:240-4.
29. Wooley AL, Hogikyan ND, Gates GA, et al. Effect of blood transfusion on recurrence of head and neck carcinoma. Retrospective review and meta-analysis. Ann Otol Rhinol Laryngol 1992;101:724-30.
30. Van de Watering LMG, Brand A, Houbiers JG, et al. Perioperative blood transfusions, with or without allogeneic leukocytes, relate to survival, not to cancer recurrence. Br J Surg 2001;88:267-72. (Pubitemid 32142717)
31. Lange MM, van Hilten JA, van de Watering LMG, et al. Leucocyte depletion of perioperative blood transfusion does not affect long-term survival and recurrence in patients with gastrointestinal cancer. Br J Surg 2009;96:734-40.
32. Sturgis EM, Congdon DJ, Mather JF, Miller RH. Perioperative transfusion, postoperative infection, and recurrence of head and neck cancer. South Med J 1997;90:1217-24.
33. Beddeberg F, Schimmer BB, Spahn DR. Transfusion-transmissible infections and transfusion-related immunomodulation. Best Pract Res Clin Anaesthesiol 2008;22:503-17.
34. Anderson B, Harken A. Multiple organ failure: inflammatory priming and activation sequences promote autologous tissue injury. J Trauma 1990;30(12 Suppl):S44-9.
35. Silliman CC, Boshkov L, Mehdizadehkashi Z, et al. Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factors. Blood 2003;101:454-62. (Pubitemid 36077563)
36. Popovsky M, Moore S. Diagnostic and pathogenetic considerations in transfusion-related acute lung injury. Transfusion 1985;25:573-7. (Pubitemid 16174471)
37. Van de Watering LMG, Hermans J, Houbiers JG, et al. Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: a randomized clinical trial. Circulation 1998;97:562-8. (Pubitemid 28090685)
38. Bilgin Y, Van de Watering LMG, Eijsman L, et al. Double-blind, randomized controlled trial on the effect of leukocyte-depleted erythrocyte transfusions in cardiac valve surgery. Circulation 2004;109:2755-60. (Pubitemid 38744552)
39. Wallis JP, Chapman CE, Orr KE, et al. Effect of WBC reduction of transfused RBCs on postoperative infection rates in cardiac surgery. Transfusion 2002;42:1127-34.
40. Weber RS. A model for predicting transfusion requirements in head and neck surgery. Laryngoscope 1995;105:1-17.
41. Taniguchi Y, Okura M. Prognostic significance of perioperative blood transfusion in oral cavity squamous cell carcinoma. Head Neck 2004;25:931-6.